GLYAT and prostate carcinoma: Treatment of prostate cancer cells with PTx reduced proliferation of GFP-expressing cells to a level comparable to that of Gαt-expressing cells (Figure 2A), indicating the primary involvement of Gβγ subunits released from Gi/o proteins.